WINDTREE THERAPEUTICS INC /DE/ Billings in Excess of Cost, Current
WINDTREE THERAPEUTICS INC /DE/ (WINT) had Billings in Excess of Cost, Current of $926.00 thousand as of 2012-12-31, per its 10-K filed 2013-03-15.
Discontinued › Notes
us-gaap:BillingsInExcessOfCostCurrent · last filed 2013-03-15
- 2012-12-31: Billings in Excess of Cost, Current $926.00K.
- 2011-12-31: Billings in Excess of Cost, Current $917.00K.
| Period end | Billings in Excess of Cost, Current |
|---|---|
| 2012-12-31 | $926.00K 10-K · filed 2013-03-15 |
| 2011-12-31 | $917.00K 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |